SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008960
Filing Date
2022-05-10
Accepted
2022-05-10 16:07:53
Documents
86
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20220331.htm   iXBRL 10-Q 2362370
2 EX-10.1 eftr-ex10_1.htm EX-10.1 168538
3 EX-31.1 eftr-ex31_1.htm EX-31.1 20469
4 EX-31.2 eftr-ex31_2.htm EX-31.2 20428
5 EX-32.1 eftr-ex32_1.htm EX-32.1 11427
6 EX-32.2 eftr-ex32_2.htm EX-32.2 11392
  Complete submission text file 0000950170-22-008960.txt   10992909

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20220331_def.xml EX-101.DEF 366215
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20220331_lab.xml EX-101.LAB 631852
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20220331_cal.xml EX-101.CAL 40050
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20220331.xsd EX-101.SCH 87532
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20220331_pre.xml EX-101.PRE 512468
80 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20220331_htm.xml XML 2138079
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 22909605
SIC: 2834 Pharmaceutical Preparations